Cisplatin-Induced Ototoxicity

临床试验

计划入组 80 人 · 首次发布于 2020 年 3 月 2 日

终止

NCT04226456

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

计划入组 19 人 · 首次发布于 2020 年 1 月 13 日

已完成

NCT01139281

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

计划入组 15 人 · 首次发布于 2010 年 6 月 8 日

药物

查看全部 223 →

Small Molecule

Approved

Cisplatin(Platinol)

生产企业：App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc，另有 3 家

相关疾病：Advanced Ovarian Cancer, Ovarian Cancer Metastatic，另有 3 项

Cl₂H₆N₂Pt · Rx

cisplatin micelle

Cisplatin/Vinblastine

机构

Intensity Therapeutics

United States

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

Veru Inc

United States

资讯

查看全部 2167 →

5个月前

Norgine Receives Swiss Approval for PEDMARQSI, First Treatment to Prevent Cisplatin-Induced Hearing Loss in Children

去年

NICE Recommends Pedmarqsi as First NHS Treatment for Cisplatin-Induced Hearing Loss in Children

2年前

临床试验

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

药物

Cisplatin(Platinol)

cisplatin micelle

Cisplatin/Vinblastine

机构

Intensity Therapeutics

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

Veru Inc

资讯

Norgine Receives Swiss Approval for PEDMARQSI, First Treatment to Prevent Cisplatin-Induced Hearing Loss in Children

NICE Recommends Pedmarqsi as First NHS Treatment for Cisplatin-Induced Hearing Loss in Children

Sensorion's SENS-501 Shows Promise in Gene Therapy for OTOF-Related Hearing Loss